期刊文献+

心力衰竭患者存活心肌与心脏再同步化治疗响应的关系

Relationship between myocardial viability in stress echocardiography and response to cardiac resynchronization therapy in patients with heart failure
下载PDF
导出
摘要 目的利用负荷三维超声心动图检测心力衰竭患者心肌的存活性,探讨心力衰竭患者存活心肌与心脏再同步化治疗(cardiac resynchronization therapy,CRT)响应的关系。方法心力衰竭患者28例,CRT术前检测心脏同步性参数(左、右心室同步性和左心室内同步性参数),同时于术前一周行药物多巴酚丁胺负荷超声试验(DSE),CRT术后复查超声心动图检测心力衰竭患者的CRT响应。结果 28例心力衰竭患者中,17例(61%)CRT术后存在响应,CRT响应组存活心肌患者比例[88%(15/17)vs.18%(2/11),P<0.001]、存活心肌的节段数[(9.2±2.3)节vs(3.4±1.9)节,P<0.001]与CRT无响应组比较,差异有统计学意义。对照同步性参数,两组左、右心室收缩延迟差值[(73±24)ms vs.(46±22)ms,P=0.005]、左心室内同步性参数左心室短轴各个节段径向应变峰值延迟最大差值(RS)[(212±81)ms vs.(147±62)ms,P=0.032]、四腔心切面各个节段横向应变峰值延迟最大差值(TS)[(219±84)ms vs.(160±63)ms,P=0.044]比较,差异有统计学意义。结论心力衰竭患者存活心肌的存在对CRT的响应起重要作用,在分析心脏同步性的同时,心肌的存活性也是一个预测心力衰竭患者CRT响应的重要指标。 Objectives Three-dimensional dobutamine stress echocardiography was used to assess myocardial viability in patients with heart failure. The aim of this study was to evaluate the role of myocardial viability in predicting response to cardiac resynchronization therapy(CRT) in patients with heart failure. Methods Twenty-eight patients with heart failure were selected. Echocardiographic techniques were used to measure interventricular and intraventricular dyssynchrony before CRT. Meanwhile, three-dimensional dobutamine stress echocardiography(DSE) was performed to determine myocardial viability one week before pacing implantation. Global functional recovery and detection of viable myocardium were identified if left ventricular ejection fraction(EF) had improved by 5% in 3D echocardiography.Follow-up echocardiography was performed 6 to 12 months after CRT. Response to CRT was defined by a 5-point scale in EF after CRT. Results During the follow-up period after CRT, 17 patients(61%) were responders, as defined by a 5-point scale in EF after CRT. The parameters between responders and non-responders were as follows : patients with viable myocardium [88%(15 / 17) vs. 18%(2 / 11), P〈0.001 ]; numbers of viable myocardial segments [(9.2 ±2.3)vs.(3.4±1.9), P〈0.001 ]; interventricular mechanical delay [(73±24) ms vs.(46±22) ms, P=0.005 ]; opposing wall delay of short-axis radial strain(RS) [(212 ±81) ms vs.(147 ±62) ms, P =0.032 ]; and opposing wall delay of transverse strain(TS) in apical views with intraventricular dyssynchrony [(219 ±84) ms vs.(160 ±63) ms, P =0.044 ].The differences were significant. Conclusions Three-dimensional dobutamine stress echocardiography may have an important role in identifying CRT responders and the presence of viable myocardium is a stronger predictor of response to CRT compared with left ventricular mechanical dyssynchrony.
出处 《岭南心血管病杂志》 2015年第3期326-328,337,共4页 South China Journal of Cardiovascular Diseases
关键词 心力衰竭 存活心肌 同步性 负荷超声心动图 heart failure viable myocardium dyssynchrony stress echocardiography
  • 相关文献

参考文献7

  • 1高鹏,范静波,程康安,陈太波,程中伟,方全.心脏同步化治疗慢性心力衰竭疗效及临床经验总结[J].岭南心血管病杂志,2011,17(2):100-103. 被引量:6
  • 2BLEEKER G B, KAANDORP T A, LAMB H J,et al. Effectof posterolateral scar tissue on clinical and echocardiographicimprovement after cardiac resynchronization therapy [J]. Circulat -ion, 2006, 113(7): 969-976.
  • 3FAROOQ A C, AJAY S, SRIPAL B, et al. Inotropic contractilereserve and response to cardiac resynchronization therapy inpatients with markedly remodeled left ventricle [J]. J Am SocEchocardiogr, 2011,24(1): 91-97.
  • 4张宁,徐标,孙步高,杨益宁.心肌梗死患者负荷三维超声心动图与冠脉介入治疗结果的对照分析[J].中国超声医学杂志,2012,28(3):243-246. 被引量:8
  • 5LIZELLE H, CARLY J,LEANNE J, et al. Incremental valueof strain rate analysis as an adjunct to wall-motion scoring forassessment of myocardial viability by dobutamineechocardiography : a follow-up study after revascularization [ J ].Circulation, 2005, 112(25): 3892-3900.
  • 6HIDEKAZU T, HANS-JOACHIM N, THOMAS B, et al.Dyssynchrony by speckle-tracking echocardiography andresponse to cardiacresynchronization therapy: results of theSpeckle Tracking and Resynchronization (STAR) study [J]. EurHeart J,2010,31(14): 1690-1700.
  • 7吕函璐,刘英梅.超声心动图预测心脏再同步化治疗反应的进展[J].岭南心血管病杂志,2012,18(5):553-556. 被引量:1

二级参考文献25

  • 1EPSTEIN A E, DIMARCO J P, ELLENBOGEN K A, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities : a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons [ J ]. Circulation, 2008,117 ( 21 ) : e350-e408.
  • 2MOSS A J, HALL W J, CANNOM D S, et al. MADIT-CRT trial investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events [J]. N Engl J Med, 2009, 361(14) : 1329-1338.
  • 3TANG A S, WELLS G A, TALAJIC M, et al. Cardiacresynchronization therapy for mild-to-moderate heart fai|ure [J ]. N Engl J Med, 2010, 363(25), 2385-2395.
  • 4YOUNG J B, ABRAHAM W T, SMITH A, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD trial[J]. JAMA, 2003, 289(20): 2685-2694.
  • 5CLELAND J G, DAUBERT J C, ERDMANN E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure for the cardiac resynchronization-heart failure (CARE-HF) study investigators [J]. N Engl J Med, 2005, 352 (15) : 1539-1549.
  • 6MOLHOEK S G, BAX J J, ERVEN L, et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy idiopathic dilated cardiomyopathy [ J ]. Am J Cardiol, 2004, 93 (7) : 860-863.
  • 7UPADHYAY G A, CHOUDHRY N K, AURICCHIO A, et al. Cardiac resynchronization in patients with atrial fibrillation: Meta-analysis of prospective cohort studies[J]. J Am Coll Cardiol, 2008, 52(15) : 1239-1246.
  • 8CAZEAU S, LECLERCQ C, LAVERGNE T, et al. Effect of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay for the multisite stimulation in cardiomyopathies (MUSTIC) study investigators [J]. N Engl J Med, 2001,344(12) : 873-880.
  • 9ABRAHAM W T, FISHER W G, SMITH D, et al. Cardiac resynchronization in chronic heart failure for the MIRACLE study group[J]. N Engl J Med, 2002,346(24): 1845-1853.
  • 10BRISTOW M R, SAXON L A, BOEHMER J, et al. Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure for the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) investigators [ J ]. N Engl J Med, 2004,350(21 ) : 2140-2150.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部